Items where Author is "McArdle, SEB"

HABRA, K., PEARSON, J.R.D., LE VU, P., PUIG‐SAENZ, C., CRIPPS, M.J., KHAN, M.A., TURNER, M.D., SALE, C. and MCARDLE, S.E.B., 2023. Anticancer actions of carnosine in cellular models of prostate cancer. Journal of Cellular and Molecular Medicine. ISSN 1582-1838

MCARDLE, S.E.B., PAWELEC, G., POCKLEY, A.G. and JOHANSEN, P., 2021. Editorial: Frontiers’ research topic “cancer vaccines: time to think differently!”. Frontiers in Immunology, 12: 771319. ISSN 1664-3224

HABRA, K., MCARDLE, S.E.B., MORRIS, R.H. and CAVE, G.W.V., 2021. Synthesis and functionalisation of superparamagnetic nano-rods towards the treatment of glioblastoma brain tumours. Nanomaterials, 11 (9): 2157. ISSN 2079-4991

CUZZUBBO, S., MANGSBO, S., NAGARAJAN, D., HABRA, K., POCKLEY, A.G. and MCARDLE, S.E.B., 2021. Cancer vaccines: adjuvant potency, importance of age, lifestyle, and treatments. Frontiers in Immunology, 11: 615240. ISSN 1664-3224

PEARSON, J.R.D., CUZZUBBO, S., MCARTHUR, S., DURRANT, L.G., ADHIKAREE, J., TINSLEY, C.J., POCKLEY, A.G. and MCARDLE, S.E.B., 2020. Immune escape in glioblastoma multiforme and the adaptation of immunotherapies for treatment. Frontiers in Immunology, 11: 582106.

ALVES, R., MCARDLE, S.E.B., VADAKEKOLATHU NARAYANAN, J., GONÇALVES, A.C., FREITAS-TAVARES, P., PEREIRA, A., ALMEIDA, A.M., SARMENTO-RIBEIRO, A.B. and RUTELLA, S., 2020. Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α. Journal of Translational Medicine, 18: 2. ISSN 1479-5876

HOOD, S.P., FOULDS, G.A., IMRIE, H., REEDER, S., MCARDLE, S.E.B., KHAN, M. and POCKLEY, A.G., 2019. Phenotype and function of activated natural killer cells from patients with prostate cancer: patient-dependent responses to priming and IL-2 activation. Frontiers in Immunology, 9: 3169. ISSN 1664-3224

FOULDS, G.A., VADAKEKOLATHU, J., ABDEL-FATAH, T.M.A., NAGARAJAN, D., REEDER, S., JOHNSON, C., HOOD, S., MOSELEY, P.M., CHAN, S.Y.T., POCKLEY, A.G., RUTELLA, S. and MCARDLE, S.E.B., 2018. Immune-phenotyping and transcriptomic profiling of peripheral blood mononuclear cells from patients with breast cancer: identification of a 3 gene signature which predicts relapse of triple negative breast cancer. Frontiers in Immunology, 9: 2028. ISSN 1664-3224

ABDEL-FATAH, T.M.A., MCARDLE, S.E.B., JOHNSON, C., MOSELEY, P.M., BALL, G.R., POCKLEY, A.G., ELLIS, I.O., REES, R.C. and CHAN, S.Y.T., 2014. HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer. British Journal of Cancer, 110 (10), pp. 2450-2461. ISSN 1532-1827

VADAKEKOLATHU, J., MILES, A.K., BOOCOCK, D.J. and MCARDLE, S.E.B., 2014. Identification of tumor antigens for clinical evaluation. In: Tumor immunology and immunotherapy. Oxford: Oxford University Press, pp. 127-129. ISBN 9780199676866

SAIF, J.M.S., VADAKEKOLATHU, J., RANE, S.S., MCDONALD, D., AHMAD, M., MATHIEU, M., POCKLEY, A.G., DURRANT, L., METHERINGHAM, R., REES, R.C. and MCARDLE, S.E.B., 2014. Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. European Journal of Immunology, 44 (4), pp. 994-1004. ISSN 0014-2980

MCARDLE, S.E.B., POCKLEY, A.G., GIBSON, G.R. and REES, R.C., 2014. Prostate cancer: important steps and considerations in the design of therapeutic vaccines. OncoImmunology, 3 (3). ISSN 2162-402X

LAVERSIN, S.A.-S., PHATAK, V.M., POWE, D.G., LI, G., MILES, A.K., HUGHES, D.C., BALL, G.R., ELLIS, I.O., GRITZAPIS, A.D., MISSITZIS, I., MCARDLE, S.E.B. and REES, R.C., 2013. Identification of novel breast cancer-associated transcripts by uniGene database mining and gene expression analysis in normal and malignant cells. Genes, Chromosomes and Cancer, 52 (3), pp. 316-329. ISSN 1098-2264

LINLEY, A.J., MATHIEU, M.G., MILES, A.K., REES, R.C., MCARDLE, S.E.B. and REGAD, T., 2012. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tunor cell proliferation in vivo. Journal of Biological Chemistry, 287 (17), pp. 13633-13643.

MATHIEU, M.G., LINLEY, A.J., REEDER, S.P., BADOUAL, C., TARTOUR, E., REES, R.C. and MCARDLE, S.E.B., 2010. HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers. Cancer Immunity, 10, p. 2.

KAPOOR, K.N., BARRY, D.T., REES, R.C., DODI, I.A., MCARDLE, S.E.B., CREASER, C.S. and BONNER, P.L.R., 2009. Estimation of peptide concentration by a modified bicinchoninic acid assay. Analytical Biochemistry, 393 (1), pp. 138-140.

LINLEY, A.J., MILES, A.K., AL-FAWAZ, M., LU, C., MCARDLE, S.E.B., REES, R.C. and MATHIEU, M.G., 2009. Non-X-linked cancer/testis antigens: identification, expression profile and immunogenicity [review]. Current Trends in Immunology.

LI, G., ASSUDANI, D.P., LINE, A., CAO, A., MILES, A., REES, R.C. and MCARDLE, S.E.B., 2008. Identification of metastasis associated antigen 1 (MTA1) by serological screening of prostate cancer cDNA libraries. Open Biochemistry Journal, 2, pp. 100-107.

LI, G., ASSUDANI, D.P., MCARDLE, S.E.B. and REES, R.C., 2007. SEREX analysis of prostate cancer cDNA libraries: the identification of MTA1 as a wide-spread tumour associate protein. Cancer Immunology Immunotherapy, 56 (1), pp. 70-80.

ROJAS, J.M., MCARDLE, S.E.B., HORTON, R.B.V., BELL, M., MIAN, S., LI, G., ALI, S.A. and REES, R.C., 2005. Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta 1*0101-and HLA-DRbeta 1*0401-restricted epitope from p53. Cancer Immunology Immunotherapy, 54 (3), pp. 243-253. ISSN 0340-7004